Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study
- 6 August 2008
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 214 (1) , 112-116
- https://doi.org/10.1016/j.expneurol.2008.07.021
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin NeuronsJournal of Neuroscience, 2006
- Non-motor symptoms of Parkinson's disease: diagnosis and managementThe Lancet Neurology, 2006
- Dopaminergic regulation of orexin neuronsEuropean Journal of Neuroscience, 2005
- Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndromeMovement Disorders, 2004
- Overlapping distributions of orexin/hypocretin‐ and dopamine‐β‐hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stressJournal of Comparative Neurology, 2003
- Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET studyMovement Disorders, 1999
- Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]RacloprideMovement Disorders, 1997
- [ 11 C]raclopride and positron emission tomography in previously untreated patients with Parkinson's diseaseNeurology, 1994
- Effect of Age on D2 Dopamine Receptors in Normal Human Brain Measured by Positron Emission Tomography and 11C-RacloprideArchives of Neurology, 1993
- Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomographyAnnals of Neurology, 1992